Sun Pharma MD Dilip Shanghvi expects own products in 2-3 years

Posted On Sep 15 2016 by

#sun pharma products # Sun Pharma MD Dilip Shanghvi expects own products in 2-3 years BS Reporter | Hyderabad Jul 30, 2015 06:54 PM IST Sun Pharmaceutical Industries Limited managing director Dilip Shanghvi today said he expects to have their own innovative products registered in the next 2-3 years in the US and that moment would also validate his belief that one need not spend $2.5 billion in research to develop a new product. Sun Pharma Advanced Research Company (Sparc), which was created over eight years ago by Sun Pharma by spinning off its research activity, has its 3 innovative …


Boehringer Ingelheim – sales performance, data and rankings – Top Pharma List

Posted On Sep 15 2016 by

#boehringer pharmaceuticals # Boehringer Ingelheim Data by GlobalData GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value. To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com Featured jobs Director, Scientific Services Great salary and benefits ID Search Selection Director, Scientific Services 80 – 100,000 or more according to skills and experience + …


Euro pharma

Posted On Sep 14 2016 by

#euro pharma # Since its inception in 1977, Am-Europharma Corporation’s vision is to adhere to International Quality Standards. In line with this vision, the company gives focus on expanding its technical capabilities in manufacturing through continuous facilities enhancement, product innovation projects, quality assurance compliance, manufacturing process improvements and personnel technical trainings. In the year 2014, Am-Europharma Corporation has changed its business model from being a manufacturer of branded and generic pharmaceutical products for its own requirements to a full-fledged toll manufacturer. With this approach, the company has opened its manufacturing facility and capabilities to various Principals who are in need …


Purdue Pharma issues statement on OxyContin report; L

Posted On Sep 14 2016 by

#purdue pharmaceutical # Purdue Pharma issues statement on OxyContin report; L.A. Times responds urdue Pharma issued a statement Friday defending its best-selling painkiller, OxyContin, and criticizing a Los Angeles Times report that the medication wears off early in many patients, exposing them to increased risk of addiction. OxyContin s main selling point is that it relieves pain for 12 hours. The Times investigation found that when the effects don t last, patients can suffer excruciating symptoms of narcotic withdrawal, including intense craving for the drug. The article said that Purdue had held fast to 12-hour dosing in part for financial …


Euro Pharma – Representatives for Pharmaceutical Manufacturers – Pharmaceutical Technology

Posted On Sep 14 2016 by

#euro pharma # Euro Pharma – Representatives for Pharmaceutical Manufacturers Euro Pharma was established in 2003 with an objective of representing leading manufacturers of bulk drug intermediate products and generic pharmaceutical medicine in India. BULK DRUG IMPORTERS, EXPORTERS AND MANUFACTURERS Euro Pharma represents a dynamic and fast growing group of companies, including importers, exporters and manufacturer representatives. Associates of the company develop and manufacture products in multi-location state-of-the-art facilities, using kilo-labs, pilot plants and full commercial production plants. We are a global marketing company supported by our associated company in India. They manufacture products as per the international quality standard …


Purdue Pharma LP Company Information

Posted On Sep 14 2016 by

#purdue pharmaceutical # Purdue Pharma LP Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? …


Differences in Academia, research Institute and Pharma company: scientific point of view

Posted On Sep 14 2016 by

#pharma research # Differences in Academia, research Institute and Pharma company: scientific point of view It’s been a while since I got back from Novartis campus. In previous posts I was writing about the scientific mission, its purposes and its course. After this experience, I can compare Academia, research Institute and Pharmaceutical company approaches to the research and science. However, it has to be emphasized, that in the following article I am comparing the Czech Academia, Dutch Institute and Swiss company, as the national background has a huge impact on the final working feelings. So here we go: Charles University, …